Clinical Trial Update: Islet Cell Transplantation Alone and CD34+ Donor Bone Marrow Cell Infusion in Type 1 Diabetes Mellitus [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluating islet cell transplantation with CD34+ donor bone marrow cell infusion for Type 1 diabetes mellitus was terminated, with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• CD34+ donor bone marrow cell infusion
• Islet cell transplantation

Snippet

Sponsor: University of Miami | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: TERMINATED | Results posted: 2014-02-10